Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 21st October 2020 from 07:00 AM to 07:00 PM (BST).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.



Recent progress of therapeutic peptide based nanomaterials: from synthesis and self-assembly to cancer treatment

Author affiliations

Abstract

Peptides have shown great potential in cancer treatment due to their good biocompatibility and low toxicity. However, the bioavailability and adverse immune response of peptides limit their further translation from bench to bedside. Over the past few decades, various peptide-based nanomaterials have been developed for drug delivery and cancer treatment. Compared with therapeutic peptides alone, self-assembled peptide nanomaterials have obvious advantages, such as improved stability and biodistribution for high-performance cancer therapy. In this review, we have described the synthesis, self-assembly and the anti-cancer application of therapeutic peptides and their conjugates, particularly polymer–peptide conjugates (PPCs).

Graphical abstract: Recent progress of therapeutic peptide based nanomaterials: from synthesis and self-assembly to cancer treatment

Back to tab navigation

Article information


Submitted
14 Aug 2020
Accepted
10 Sep 2020
First published
10 Sep 2020

Biomater. Sci., 2020, Advance Article
Article type
Review Article

Recent progress of therapeutic peptide based nanomaterials: from synthesis and self-assembly to cancer treatment

R. Guo, X. Zhang, L. Ji, Z. Wei, Z. Duan, Z. Qiao and H. Wang, Biomater. Sci., 2020, Advance Article , DOI: 10.1039/D0BM01358G

Social activity

Search articles by author

Spotlight

Advertisements